Prediction of therapeutic response to pregabalin in subjects with neuropathic pain
Author:
Affiliation:
1. Pfizer Inc, New York, NY, USA
Publisher
Informa UK Limited
Subject
General Medicine
Link
https://www.tandfonline.com/doi/pdf/10.1080/03007995.2018.1520694
Reference46 articles.
1. Neuropathic pain in the general population: A systematic review of epidemiological studies
2. Burden of illness associated with painful diabetic peripheral neuropathy among adults seeking treatment in the US: results from a retrospective chart review and cross-sectional survey
3. A cross-sectional survey of health state impairment and treatment patterns in patients with postherpetic neuralgia
4. Burden of spinal cord injury-related neuropathic pain in the United States: retrospective chart review and cross-sectional survey
Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Key use cases for artificial intelligence to reduce the frequency of adverse drug events: a scoping review;The Lancet Digital Health;2022-02
2. Pregabalin for neuropathic pain in primary care settings: recommendations for dosing and titration;Postgraduate Medicine;2021-01-02
3. Clinical efficacy and tolerability of Gabapentinoids with current prescription patterns in patients with Neuropathic pain;Pakistan Journal of Medical Sciences;2019-10-05
4. The relationship between the reporting of euphoria events and early treatment responses to pregabalin: an exploratory post-hoc analysis;Journal of Pain Research;2019-08
The relationship between the reporting of euphoria events and early treatment responses to pregabalin: an exploratory post-hoc analysis
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3